11
1
16
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9920 |
Evolocumab
|
Others | Others |
Evolocumab 是人源化单克隆抗体PCSK9的抑制剂。它与循环的 PCSK9 蛋白结合,使得PCSK9与 LDLR 结合受到抑制。它可用研究于高胆固醇血症以及动脉粥样硬化性心血管疾病的研究。 | |||
T9276 |
SBC-115337
|
Others; Serine/threonin kinase | Cell Cycle/Checkpoint; Metabolism; Others |
SBC-115337 是苯并呋喃化合物,也是 PCSK9抑制剂 (IC50:0.5 μM) 。 | |||
T15561 |
Imanixil
HOE-402(free base) |
Others | Others |
Imanixil is an inducer of the LDL receptor (LDLR) and it is also a potent cholesterol-lowering compound. It also inhibits very low density-lipoprotein (VLDL) production and consequently decreases atherosclerosis development. | |||
T67776 |
PCSK9-IN-11
|
Others | Others |
PCSK9-IN-11 (compound 5r) 是口服有效的 PCSK9 抑制剂。 PCSK9-IN-11 在 HepG2 细胞中抑制 PCSK9 转录活性 (IC50= 5.7 μM)。 PCSK9-IN-11 可以增加 LDL 受体 (LDLR) 蛋白水平,可用于动脉粥样硬化研究。 | |||
T72025 |
PCSK9-IN-10
|
Serine/threonin kinase | Cell Cycle/Checkpoint; Metabolism |
PCSK9-IN-10 是一种有效的,具有口服活性的PCSK9抑制剂,IC50值为 6.4 µM。PCSK9-IN-10 增加LDLR 蛋白的表达并降低 PCSK9 的表达。PCSK9-IN-10 可减缓动脉粥样硬化进展。PCSK9-IN-10 具有研究高脂血症的潜力。 | |||
T78806 |
PPARδ agonist 9
|
PPAR | DNA Damage/DNA Repair; Metabolism |
PPARδ agonist9 (compound 21) 作为PPARδ激动剂,展现出EC50为3.6 nM的活性。在体内实验中,PPARδ agonist9能有效降低小鼠血清中MCP-1水平,并在LDLr-KO模型中显著抑制动脉粥样硬化的发展,其抑制率达50-60%。 | |||
T81535 |
PCSK9-IN-20
|
||
PCSK9-IN-20(Compound 3i)作为一种PCSK9抑制剂,具有IC50为 3.96 µM,能有效降低体外PCSK9水平并提升LDLR蛋白表达。 | |||
T39528 |
PCSK9-IN-2
PCSK9-IN-2 |
||
PCSK9-IN-2 is a newly developed small molecule that effectively inhibits the protein-protein interaction (PPI) between PCSK9 and LDLR. It has been found to have a potent inhibitory activity with an IC50 value of 7.57 μM. | |||
T77014 | Frovocimab | ||
Frovocimab (LY 3015014)为一种人源化IgG4单克隆抗体(mAb),其功能为中和PCSK9,通过抑制PCSK9与LDL受体(LDLR)的结合,促使已结合的PCSK9正常进行蛋白水解切割。 | |||
T74577 |
Milpocitide
|
||
Milpocitide为针对低密度脂蛋白受体(human LDL receptor, LDLR)(293-333)的肽片段(EGF-like domain 1)的化合物。 | |||
T78718 | Dim16 | ||
Dim16是一种同时抑制PCSK9和HMG-CoAR的化合物,其对PCSK9的IC50为19 nM,并且能够阻断PCSK9与LDLR的结合,此作用的IC50为0.8 nM。Dim16还能提升HepG2细胞对LDL的吸收。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5S0053 |
Coptisine
黄连碱,Coptisin |
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
Coptisine (Coptisin) 是一种从黄连中分离到的生物碱,是非竞争性的IDO 抑制剂,Ki=为 5.8 μM,IC50=6.3 μM。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00989 |
LDLR Protein, Human, Recombinant (His)
low density lipoprotein receptor,FHC,FH,LDLCQ2,LDL Receptor,... |
Human | HEK293 Cells |
LDLR Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 86 kDa and the accession number is A0A024R7D5. | |||
TMPJ-00394 |
LDLR Protein, Human, Recombinant (Avi & His), Biotinylated
Low-Density Lipoprotein Receptor,LDL Receptor,LDLR |
Human | HEK293 Cells |
Low-density lipoprotein receptor 9 (LDL receptor) is a single-pass type I membrane protein which belongs to the LDLR family. It contains 3 EGF-like domains, 7 LDL-receptor class A domains, and 6 LDL-receptor class B repeats. This protein binds LDL, the major cholesterol-carrying lipoprotein of plasma, and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. In case of HIV-1 infection, it functions as a r... | |||
TMPK-01297 |
LDLR Protein, Cynomolgus, Recombinant (His)
LDLR,LDL R,LDL receptor,FH,LDLCQ2,FHC |
Cynomolgus | HEK293 Cells |
The low density lipoprotein receptor (LDLR) is the founding member of the LDL R family of widely expressed cell surface scavenger receptors. It is a cell-surface receptor that recognizes the apoprotein B100 which is embedded in the phospholipid outer layer of LDL particles. LDLR Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 86 kDa and the accession number is XP_005588053.1. | |||
TMPK-00402 |
LDLR Protein, Human, Recombinant (His & Avi)
FH,LDLCQ2,LDL R,LDLR,FHC,LDL receptor |
Human | HEK293 Cells |
The low density lipoprotein receptor (LDLR) is the founding member of the LDL R family of widely expressed cell surface scavenger receptors. It is a cell-surface receptor that recognizes the apoprotein B100 which is embedded in the phospholipid outer layer of LDL particles. LDLR Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 87.6 kDa and the accession number is P01130-1. | |||
TMPY-01014 |
LDLR Protein, Mouse, Recombinant (His)
low density lipoprotein receptor,Hlb301 |
Mouse | HEK293 Cells |
LDLR Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 85.7 kDa and the accession number is P35951. | |||
TMPY-05323 |
LDLR Protein, Human, Recombinant (mFc)
LDL R,FH,LDLCQ2,LDL Receptor,low density lipoprotein recepto... |
Human | HEK293 Cells |
LDLR Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 111.2 kDa and the accession number is A0A024R7D5. | |||
TMPY-05499 |
LDLR Protein, Human, Recombinant (His), Biotinylated
LDL Receptor,LDL R,low density lipoprotein receptor,FHC,FH,L... |
Human | HEK293 Cells |
LDLR Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 86 kDa and the accession number is A0A024R7D5. | |||
TMPY-05348 |
LDLR Protein, Mouse, Recombinant (His), Biotinylated
Hlb301,low density lipoprotein receptor |
Mouse | HEK293 Cells |
LDLR Protein, Mouse, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 85.7 kDa and the accession number is P35951. | |||
TMPY-05809 |
LDLR Protein, Human, Recombinant (193D/A, His)
low density lipoprotein receptor,LDL R,LDL Receptor,FHC,FH,L... |
Human | HEK293 Cells |
LDLR Protein, Human, Recombinant (193D/A, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 86.19 kDa and the accession number is A0A024R7D5. | |||
TMPY-01085 |
VLDLR Protein, Human, Recombinant (His)
VLDLRCH,CAMRQ1,CHRMQ1,very low density lipoprotein ... |
Human | HEK293 Cells |
The very low density lipoprotein receptor, known as VLDLR, is a single-pass type 1 integral membrance protein and a member of the LDL receptor family. This receptor family includes LDL receptor, LRP, megalin, VLDLR and ApoER2, and is characterized by a cluster of cysteine-rich class A repeats, epidermal growth factor (EGF)-like repeats, YWTD repeats and an O-linked sugar sdomain. VLDLR contains 3 EGF-like domains, 8 LDL-receptor class A domains, as well as 6 LDL-receptor class B repeats, and is ... | |||
TMPY-00383 |
LDLRAD3 Protein, Human, Recombinant (hFc)
LRAD3,low density lipoprotein receptor class A domain contai... |
Human | HEK293 Cells |
LDLRAD3 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 43.8 kDa and the accession number is Q86YD5-1. | |||
TMPK-00928 |
VLDLR Protein, Mouse, Recombinant (His)
CHRMQ1,VLDLR,FLJ35024,VLDLRCH,RP11-320E16.... |
Mouse | HEK293 Cells |
VLDLR cerebellar hypoplasia (VLDLR-CH) is characterized by non-progressive congenital ataxia that is predominantly truncal and results in delayed ambulation, moderate-to-profound intellectual disability, dysarthria, strabismus, and seizures.VLDLR-CH is inherited in an autosomal recessive manner. Carrier testing for at-risk relatives, prenatal testing for a pregnancy at increased risk and preimplantation genetic testing are possible when the pathogenic variants in a family are known. | |||
TMPY-01451 |
MESDC2 Protein, Human, Recombinant (His)
MESD,mesoderm development candidate 2,BOCA |
Human | HEK293 Cells |
MESD (Mesoderm Development LRP Chaperone) is a Protein Coding gene. LDLR chaperone MESD, also known as Mesoderm development protein, Mesoderm development candidate 2, Renal carcinoma antigen NY-REN-61, and MESDC2, is a member of the MESD family. It is widely expressed in the thyroid, placenta, and other tissues. MESDC2 is a chaperone specifically assisting the folding of beta-propeller/EGF modules within the family of low-density lipoprotein receptors (LDLRs). The LDLR maturation activity reside... | |||
TMPJ-00443 |
PCSK9 Protein, Macaca nemestrina, Recombinant (His)
Proprotein Convertase Subtilisin/Kexin Type 9,PCSK9,PC9,Prop... |
Macaca nemestrina | HEK293 Cells |
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a secretory subtilase belonging to the proteinase K subfamily. PCSK9 is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the ER , the pro domain and mature chain secrete together through noncovalent interactions. PCSK9 binds with low-density lipoprotein receptor (LDLR) and plays a major regulatory role in cholesterol homeostasis. PCSK9 also plays a role in the neural development. | |||
TMPJ-01412 |
LRP-12 Protein, Human, Recombinant (His)
LRP-12,ST7,Suppressor of Tumorigenicity 7 Protein,LRP12,Low-... |
Human | HEK293 Cells |
Low-Density Lipoprotein Receptor-Related Protein 12 (LRP12) belongs to the LDLR family. LRP12 is a type I transmembrane protein annd widely expressed in heart, skeletal muscle, brain, lung, placenta and pancreas. LRP12 contains 2 CUB domain and 5 LDL-receptor class A domain. LRP12 has been shown to interact with GNB2L1, ZFYVE9 and ITGB1BP3. LRP12 is a receptor probably, which may be involved in the internalization of lipophilic molecules and/or signal transduction. In addition, LRP12 may act as ... | |||
TMPY-02604 |
UBE2D4 Protein, Human, Recombinant (His)
HBUCE1,ubiquitin-conjugating enzyme E2D 4 (putative) |
Human | E. coli |
UBE2D4 is a member of the ubiquitin-conjugating E2 family whose members perform the second step in the ubiquitination reaction. Initially identified as the main process for protein degradation, ubiquitination is believed nowadays to be crucial for a wider range of cellular processes. The outcome of the ubiquitin-conjugation reaction, and thereby the fate of the substrate, is heavily dependent on the number of ubiquitin molecules attached and how these ubiquitin molecules are inter-connected. To ... |